These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 22880124

  • 1. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.
    Poethko-Müller C, Mankertz A.
    PLoS One; 2012; 7(8):e42867. PubMed ID: 22880124
    [Abstract] [Full Text] [Related]

  • 2. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
    Gohil DJ, Kothari ST, Chaudhari AB, Gunale BK, Kulkarni PS, Deshmukh RA, Chowdhary AS.
    Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
    [Abstract] [Full Text] [Related]

  • 3. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
    Madi N, Altawalah H, Alfouzan W, Al-Nakib W, Al-Roumi E, Jeragh A.
    J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861
    [Abstract] [Full Text] [Related]

  • 4. Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India.
    Gupta M, Tripathy JP, Verma M, Singh MP, Kaur R, Ratho RK, Kumar R.
    Indian J Med Res; 2019 Mar; 149(3):396-403. PubMed ID: 31249206
    [Abstract] [Full Text] [Related]

  • 5. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L, Germann D, Bally F, Schopfer K.
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [Abstract] [Full Text] [Related]

  • 6. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
    Wang Z, Yan R, He H, Li Q, Chen G, Yang S, Chen E.
    PLoS One; 2014 Jan; 9(2):e89361. PubMed ID: 24586717
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory.
    Ghafoori F, Mokhtari-Azad T, Foroushani AR, Farahmand M, Shadab A, Salimi V.
    BMC Infect Dis; 2024 Jul 12; 24(1):696. PubMed ID: 38997625
    [Abstract] [Full Text] [Related]

  • 9. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.
    Mossong J, Putz L, Schneider F.
    Epidemiol Infect; 2004 Jan 12; 132(1):11-8. PubMed ID: 14979584
    [Abstract] [Full Text] [Related]

  • 10. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
    Gil Miguel A, Astasio Arbiza P, Ortega Molina P, Domínguez Rojas V, González López A.
    An Esp Pediatr; 1999 May 12; 50(5):459-62. PubMed ID: 10394183
    [Abstract] [Full Text] [Related]

  • 11. Immunity against measles, mumps, rubella, and varicella among homeless individuals in Germany - A nationwide multi-center cross-sectional study.
    Graf W, Bertram F, Dost K, Brennecke A, Kowalski V, van Rüth V, Nörz DS, Wulff B, Ondruschka B, Püschel K, Pfefferle S, Lütgehetmann M, Heinrich F.
    Front Public Health; 2024 May 12; 12():1375151. PubMed ID: 38784578
    [Abstract] [Full Text] [Related]

  • 12. Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015.
    Jablonka A, Happle C, Grote U, Schleenvoigt BT, Hampel A, Dopfer C, Hansen G, Schmidt RE, Behrens GM.
    Infection; 2016 Dec 12; 44(6):781-787. PubMed ID: 27449329
    [Abstract] [Full Text] [Related]

  • 13. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.
    Levine H, Zarka S, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, Balicer RD.
    Hum Vaccin Immunother; 2015 Dec 12; 11(6):1400-5. PubMed ID: 25891446
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of antibodies against measles, mumps and rubella in the childhood population in Singapore, 2008-2010.
    Ang LW, Lai FY, Tey SH, Cutter J, James L, Goh KT.
    Epidemiol Infect; 2013 Aug 12; 141(8):1721-30. PubMed ID: 22999024
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 12; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 16. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 17. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
    Saffar MJ, Fathpour GR, Parsaei MR, Ajami A, Khalilian AR, Shojaei J, Saffar H.
    J Trop Pediatr; 2011 Oct 10; 57(5):347-51. PubMed ID: 21078605
    [Abstract] [Full Text] [Related]

  • 18. Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China.
    Pang H, Zhou Y, Zhao W, Jiang Q.
    Int J Environ Res Public Health; 2018 Sep 23; 15(10):. PubMed ID: 30249033
    [Abstract] [Full Text] [Related]

  • 19. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
    Sáenz González MC, Núñez Mateos JC, Rodrigo Sánchez N, Martín Sánchez AM.
    An Esp Pediatr; 1992 Apr 23; 36(4):293-7. PubMed ID: 1605414
    [Abstract] [Full Text] [Related]

  • 20. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
    Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G, Eren S, Baykam N, Guvener E, Dokuzoguz B.
    Am J Infect Control; 2006 Nov 23; 34(9):583-7. PubMed ID: 17097453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.